Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Revenue

Kiniksa Pharmaceuticals International, had revenue of $137.79M in the quarter ending March 31, 2025, with 72.54% growth. This brings the company's revenue in the last twelve months to $481.17M, up 59.45% year-over-year. In the year 2024, Kiniksa Pharmaceuticals International, had annual revenue of $423.24M with 56.60% growth.

• Revenue (ttm): $481.17M
• Revenue Growth: +59.45%
• P/S Ratio: 4.23
• Revenue / Employee: $1,527,511
• Employees: 315
• Market Cap: 2.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	423.24M	152.98M	56.60%
Dec 31, 2023	270.26M	50.08M	22.74%
Dec 31, 2022	220.18M	181.64M	471.24%
Dec 31, 2021	38.54M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.